Aripiprazole

Aripiprazole is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. Its relevance to longevity and health optimization is mainly through its potential cognitive-enhancing effects and mood stabilization, which can contribute to improved mental health and quality of life.

Intelligence Profile

Safety Profile

Aripiprazole is an antipsychotic medication often used to treat conditions like schizophrenia and bipolar disorder. Below is a summary of its safety profile based on the available evidence.

Known Side Effects

Aripiprazole is associated with various side effects, some of which are more common than others:

Common side effects: Insomnia, headaches, dizziness, and gastrointestinal issues like nausea. Weight gain can also occur, though some studies (e.g., NCT00806234) aim to address this through adjunct therapies.
Serious side effects: Although rare, there have been reports of atypical Neuroleptic Malignant Syndrome, particularly without hyperthermia, as highlighted in a case report in Cureus (2026). This condition requires immediate medical attention.

Contraindications

The evidence did not specifically outline contraindications for aripiprazole, but typical contraindications for antipsychotics may include:

History of neuroleptic malignant syndrome
Hypersensitivity to aripiprazole
Severe cardiovascular conditions (consultation required)

Drug Interactions

Detailed interactions were not found in the current evidence set. However, caution is advised when combining aripiprazole with other psychotropic drugs due to potential interactions affecting efficacy and safety, as seen in polypharmacy patterns (Psychiatry research, 2026).

Populations to Avoid

Specific populations that should avoid aripiprazole based on this dataset are not clearly defined. Generally, caution is recommended for:

Elderly patients with dementia-related psychosis, as antipsychotic drugs have been associated with an increased risk of death in this population.
Patients with a history of cardiovascular issues, unless under close supervision.

Conclusion

Overall, aripiprazole appears to have a manageable safety profile, but attention to side effects, potential serious reactions, and general contraindications typical for antipsychotics is crucial. The evidence for specific populations and detailed interactions is thin, indicating a need for more precise studies.

Disclaimer: This summary is for informational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider for specific medical guidance.